(Q61934272)
Statements
A Phase 1, Open-Label Examination of the Dermatologic Effects From Subcutaneous Administration of ISIS 113715, and Antisense Oligonucleotide Inhibitor of Protein Tyrosine Phosphatase 1B, in Healthy Volunteers (English)
0 references
August 2006
0 references
10
0 references
18 year
0 references
65 year
0 references